These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23572296)

  • 41. Cross-talk between androgen receptor and pregnane and xenobiotic receptor reveals existence of a novel modulatory action of anti-androgenic drugs.
    Kumar S; Jaiswal B; Kumar S; Negi S; Tyagi RK
    Biochem Pharmacol; 2010 Oct; 80(7):964-76. PubMed ID: 20599793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgens and the skeleton.
    Lindberg MK; Vandenput L; Movèrare Skrtic S; Vanderschueren D; Boonen S; Bouillon R; Ohlsson C
    Minerva Endocrinol; 2005 Mar; 30(1):15-25. PubMed ID: 15877010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation.
    Garreau JR; Muller P; Pommier R; Pommier S
    Am J Surg; 2006 May; 191(5):576-80. PubMed ID: 16647340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer.
    Bimonte VM; Catanzaro G; Po A; Trocchianesi S; Besharat ZM; Spinello Z; Curreli M; Fabi A; Bei R; Milella M; Vacca A; Ferretti E; Migliaccio S
    Endocrine; 2024 Mar; 83(3):798-809. PubMed ID: 37979099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
    Lanzino M; Maris P; Sirianni R; Barone I; Casaburi I; Chimento A; Giordano C; Morelli C; Sisci D; Rizza P; Bonofiglio D; Catalano S; Andò S
    Cell Death Dis; 2013 Jul; 4(7):e724. PubMed ID: 23846226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen signalling and steroid receptor crosstalk in endocrine cancers.
    Claessens F; Tilley W
    Endocr Relat Cancer; 2014 Aug; 21(4):E3-5. PubMed ID: 25052914
    [No Abstract]   [Full Text] [Related]  

  • 48. A role for the androgen receptor in the treatment of male breast cancer.
    Zhu J; Davis CT; Silberman S; Spector N; Zhang T
    Crit Rev Oncol Hematol; 2016 Feb; 98():358-63. PubMed ID: 26669267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.
    Traish AM; Vignozzi L; Simon JA; Goldstein I; Kim NN
    Sex Med Rev; 2018 Oct; 6(4):558-571. PubMed ID: 29631981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs.
    Gao L; Bao Z; Deng H; Li X; Li J; Rong Z; Yang Y; Liu L; Nie D; Wang G; Teichmann AT; Wieland FH
    Cell Death Dis; 2019 Jun; 10(7):494. PubMed ID: 31235695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women.
    Honma N; Hosoi T; Arai T; Takubo K
    Pathol Int; 2015 Sep; 65(9):451-9. PubMed ID: 26126901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
    Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
    Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Long M; You C; Song Q; Hu LXJ; Guo Z; Yao Q; Hou W; Sun W; Liang B; Zhou X; Liu Y; Hu T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm.
    Jongen L; Paridaens R; Floris G; Wildiers H; Neven P
    Breast Cancer Res Treat; 2016 Feb; 155(3):603-7. PubMed ID: 26868122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of grape seed extract on estrogen levels of postmenopausal women: a pilot study.
    Wahner-Roedler DL; Bauer BA; Loehrer LL; Cha SS; Hoskin TL; Olson JE
    J Diet Suppl; 2014 Jun; 11(2):184-97. PubMed ID: 24670122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Revisiting Androgen Receptor Signaling in Breast Cancer.
    Dai C; Ellisen LW
    Oncologist; 2023 May; 28(5):383-391. PubMed ID: 36972361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.
    Anestis A; Zoi I; Papavassiliou AG; Karamouzis MV
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31952272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review.
    Jahan N; Jones C; Rahman RL
    Mol Cell Endocrinol; 2021 Jul; 531():111324. PubMed ID: 34000352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Androgen Receptor in Breast Cancer.
    Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Bilancio A; Migliaccio A
    Front Endocrinol (Lausanne); 2018; 9():492. PubMed ID: 30210453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer.
    Jongen VH; Sluijmer AV; Heineman MJ
    Maturitas; 2002 Oct; 43(2):77-85. PubMed ID: 12385855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.